Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{189496,
        author = {Sayli Ravindra Dabhade and Gayathri Muley and Mr.Hatkar Avinash D. and Mr.S.V.Phoke and Mr.Dr.Sunil},
        title = {Pharmacogenomics and Personalized Medicine: Transforming Modern Therapeutics},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {7},
        pages = {5996-5998},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=189496},
        abstract = {Pharmacogenomics is an emerging discipline that explores the role of genetic variations in determining individual drug response. Traditional therapeutic approaches often follow a “one-size-fits-all” model, which may result in therapeutic failure or adverse drug reactions in certain populations. Personalized medicine integrates pharmacogenomic data with clinical parameters to tailor drug selection, dosage, and treatment duration according to individual genetic profiles. This review article discusses the principles of pharmacogenomics, its molecular basis, clinical applications, role in adverse drug reaction prevention, challenges in implementation, and future prospects. The integration of pharmacogenomics into clinical practice has the potential to improve drug efficacy, enhance patient safety, and optimize healthcare outcomes.},
        keywords = {Adverse drug reactions, biomarkers, personalized medicine, pharmacogenomics, precision therapy},
        month = {December},
        }